April 18, 2014 7:48 AM ET

Biotechnology

Company Overview of Mirna Therapeutics, Inc.

Executive Profile

Paul Lammers M.D., M.Sc

Chief Executive Officer, President and Director, Mirna Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
55--

Background

Dr. Paul Lammers, MD, M.Sc has been the Chief Executive Officer and President of Mirna Therapeutics, Inc., since November 2009. Dr. Lammers served as a Secretary of Repros Therapeutics Inc. until October 29, 2009 and served as its President from February 2009 to October 29, 2009. He served as Senior Vice President of Clinical & Regulatory Affairs at Repros Therapeutics Inc. (formerly, Zonagen Incorporated) since 1998. He served as Chief Medical Officer of EMD Serono, ...

Corporate Headquarters

2150 Woodward Street
Austin, Texas 78744

United States

Phone: 512-901-0900
Fax: 512-681-5201

Board Members Memberships

2009-Present
Chief Executive Officer, President and Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mirna Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.